http://chineseinput.net/에서 pinyin(병음)방식으로 중국어를 변환할 수 있습니다.
변환된 중국어를 복사하여 사용하시면 됩니다.
진행된 장액성 상피성 난소암 환자의 혈청 CA 125 측정의 예후인자로서의 의의
이지수 ( Ji Soo Lee ),김지운 ( Ji Un Kim ),문성오 ( Sung O Moon ),최중섭 ( Joong Sub Choi ),이선주 ( Sun Joo Lee ),이정원 ( Jeong Won Lee ),박창수 ( Chang Soo Park ),김병기 ( Byoung Gie Kim ),이제호 ( Je Ho Lee ),배덕수 ( Duk Soo 대한산부인과학회 2004 Obstetrics & Gynecology Science Vol.47 No.6
Objective : In this retrospective study, we analyzed the clinicopathologic characteristics of advanced serous epithelial ovarian cancer and evaluated the prognostic factors which have an impact on survival of patients with epithelial ovarian cancer. We also compared several analyzing methods of Ca 125 for predicting prognosis of advanced serous epithelial ovarian cancer. Methods : a total of 57 patients with advanced serous epithelial ovarian cancer who were treated at Samsung Medical Center between Aug. 1995 and Jul. 2000 were included. Medical records including pathologic reports were reviewed to identify clinicopathologic characteristics and serum levels of CA 125. Five different methods of analyzing serum CA 125 were compared for predicting the prognosis of advanced serous epithelial ovarian cancer. Survival curves were analyzed by Kaplan-Meier method and Cox proportional hazards model. Results : the median age of all patients was 54.2 years. In univariate analysis, age, FIGO stage, grade, residual tumor and ascites showed no significant correlation with prognosis. Among five different analyzing methods of serum CA 125 levels, normalization after 3^rd chemotherapy was correlated with improved 5-year survival rate (p=0.026). Conclusion : this study showed that normalization of serum levels of CA 125 after 3^rd chemotherapy is useful for predicting prognosis of advanced serous epithelial ovarian cancer patients.